4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-21-001008
Director sold 5,000 shares at an average $48.12 ($240,594)
From the SEC's structured data for this filing
Trades in this filing
Kelley Kenneth J · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-01 | Sale : show line 1 in the form | −4,754 | $48.09 | $228,617 | 190,079 | D |
| 2021-02-01 | Sale : show line 2 in the form | −246 | $48.69 | $11,977 | 189,833 | D |
| Open-market sales · 5,000 sh · avg $48.12 · $240,594 | ||||||
Loading xslF345X03/edgar.xml…